2023
Candidate biomarkers in psychiatric disorders: state of the field
Abi-Dargham A, Moeller S, Ali F, DeLorenzo C, Domschke K, Horga G, Jutla A, Kotov R, Paulus M, Rubio J, Sanacora G, Veenstra-VanderWeele J, Krystal J. Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry 2023, 22: 236-262. PMID: 37159365, PMCID: PMC10168176, DOI: 10.1002/wps.21078.Peer-Reviewed Original ResearchError-related negativityAutism spectrum disorderAnxiety disordersSpectrum disorderFunctional magnetic resonance imaging (fMRI) measuresEvent-related brain potentialsPost-traumatic stress disorderSocial anxiety disorderTreatment responseCandidate biomarkersGeneralized anxiety disorderResting-state functional magnetic resonance imaging (rsfMRI) measuresDefinitive testingBrain potentialsNeuroscience literatureElectrophysiological indicesStress disorderMagnetic resonance imaging (MRI) measuresNaturalistic settingConnectomic measuresNumerous candidate biomarkersPresence of illnessMobile health toolsIndividual levelBiomarker validation process
2022
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine Study.
Feeney A, Hoeppner B, Freeman M, Flynn M, Iosifescu D, Trivedi M, Sanacora G, Mathew S, DeBattista C, Ionescu D, Cusin C, Papakostas G, Jha M, Fava M. Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine Study. The Journal Of Clinical Psychiatry 2022, 84 PMID: 36383742, DOI: 10.4088/jcp.22m14491.Peer-Reviewed Original ResearchConceptsMajor depressive disorderDifferential treatment responsePrimary outcome measureBenzodiazepine useOral benzodiazepinesTreatment responseDay 1Antidepressant effectsHigh dosesClinical Global Impressions-SeverityHamilton Depression Rating ScaleStudy's primary outcome measureIllness Scale scoresTreatment-resistant depressionRandomized clinical trialsDepression Rating ScaleBenzodiazepine dosageIntravenous ketamineConcomitant benzodiazepinesSingle infusionClinical trialsDepressive disorderKetamine studiesOutcome measuresBenzodiazepine effects